APELLIS PHARMACEUTICALS INC revenue breakdown overview

APELLIS PHARMACEUTICALS INC revenue for the last year amounted to 754.78 M EUR, the most of which — 754.78 M EUR — came from its highest performing source at the moment, Novel Therapeutic Compounds, the year earlier bringing 359.32 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought APELLIS PHARMACEUTICALS INC 685.80 M EUR, and the year before that — 359.32 M EUR.